Skip to main content
. 2017 Jul 6;44(3):620–630. doi: 10.1093/schbul/sbx081

Table 1.

Demographic and Clinical Characteristics of Participants

CHR First-Episode Chronic Statistics
Probands (N = 51) Controls (N = 36) Probands (N = 80) Controls (N = 49) Probands (N = 50) Controls (N = 39)
Age 18.7 (3.5) 20.1 (3.4) 22.8 (3.7) 22.7 (2.3) 31.2 (7.1) 32.3 (4.5) group: F1,296 = 2.16, NS
phase: F1,296 = 184.37, P < .001
group × phase: F1,296 = .96, NS
Gender (% Female) 29.4 38.9 28.7 40.8 30.6 40.5 group: χ12 = .91, NS
phase: χ12= .02, NS
group × phase: χ12 = .04, NS
Parental Edu. 12.9 (3.5) 13.7 (2.4) 13.9 (3.9) 14.5 (3.1) 14.5 (3.3) 14.8 (3.3) group: F1,296 = 1.85, NS
phase: F1,296 = 3.33, P < .05
group × phase: F1,296 = .07, NS
GRFS 6.1 (2.4) 8.6 (0.7) 3.8 (2.2) 8.0 (1.4) 4.6 (2.8) 8.9 (0.8) group: F1,217 =v142.79, P < .001
phase: F1,217 = 8.89, P < .001
group × phase: F1,217 = 3.56, P < .05
GSFS 6.2 (1.5) 9.0 (0.7) 5.3 (1.9) 8.3 (1.3) 6.3 (2.0) 8.8 (1.3) group: F1,211 = 139.54, P < .001
phase: F1,211 = 5.43, P < .001
group × phase: F1,211 = .37, NS
BPRS total 39.8 (9.1) 42.1 (12.1) 41.6 (9.4) phase: F1,162 = .71, NS
RAD 57.1 (7.3) 60.0 (5.0) 47.6 (8.4) 59.9 (5.3) 48.6 (9.7) 56.8 (8.2) group: F1,273 = 59.39, P < .001
phase: F1,273 = 11/80, P < .001
group × phase: F1,273 = 9.89, P < .001
MSCEIT
B1 109.5 (11.5) 115.7 (12.5) 99.8 (17.1) 112.1 (12.8) 98.1 (15.1) 108.2 (15.5) group: F1,260 = 20.97, P < .001
phase: F1,260 = 6.97, P < .01
group × phase: F1,260 = 1.23, NS
B2 99.5 (12.4) 106.3 (10.7) 89.1 (16.5) 105.9 (11.5) 93.3 (18.8) 105.9 (11.3) group: F1,265 = 37.84, P < .001
phase: F1,265 = 4.61, P < .05
group × phase: F1,265 = 2.77, NS
B3 92.9 (11.7) 99.7 (10.4) 82.0 (14.7) 98.6 (9.2) 84.2 (14.1) 100.2 (11.7) group: F1,264 = 65.18, P < .001
phase: F2,264 = 7.11, P < .01
group × phase: F2,264 = 3.26, P < .001
B4 83.6 (11.0) 96.6 (7.5) 88.5 (9.0) 100.5 (8.5) group: F1,193 = 78.18, P < .001
phase: F1,193 = 3.01, NS
group × phase: F1,193 = .17, NS
Total 85.0 (15.4) 104.9 (10.1) 88.1 (15.5) 105.7 (12.8) group: F1,193 = 80.89, P < .001
phase: F1,193 = .18, NS
group × phase: F1,193 =. 38, NS
MCCB
SOP 44.4 (14.6) 51.0 (901) 32.1 (14.3) 47.7 (8.7) 36.5 (11.4) 52.1 (10.8) group: F1,248 = 47.13, P < .001
phase: F2,248 = 49.42, P < .001
group × phase: F2,248 = 3.37, P < .05
AV 40.7 (9.1) 46.1 (10.5) 33.9 (10.9) 48.3 (9.1) 41.0 (11.3) 55.2 (8.7) group: F1,244 = 81.14, P < .001phase: F2,244 = 1.75, NSgroup × phase: F2,244 = 4.88, P < .01
WM 45.1 (10.1) 49.2 (8.8) 38.7 (11.4) 50.0 (9.8) 41.1 (13.6) 50.1 (13.5) group: F1,248 = 29.65, P < .001
phase: F2,248 = 1.38, NS
group × phase: F2,248 = 1.35, NS
Vrbl Lrng 45.6 (9.7) 46.4 (9.0) 37.9 (9.5) 49.2 (9.1) 41.1 (11.8) 52.3 (10.7) group: F1,248 = 31.64, P < .001
phase: F2,248 = 1.35, NS
group × phase: F2,248 = 6.85, P < .01
Vis Lrng 42.5 (11.9) 47.5 (8.1) 34.6 (10.7) 45.4 (9.1) 34.7 (13.5) 44.1 (13.4) group: F1,248 = 28.73, P < .001
phase: F2,248 = 4.57, P < .05
group × phase: F2,248 = 1.47, NS
RPS 45.7 (10.3) 46.5 (11.9) 40.1 (9.5) 47.6 (9.1) 44.4 (101) 47.0 (11.1) group: F1,248 = 6.90, P < .01
phase: F2,248 = 1.82, NS
group × phase: F2,248 = 2.22, NS
Neurocognitive composite 41.0 (12.5) 46.6 (10.1) 29.7 (12.8) 47.1 (9.0) 34.6 (13.7) 50.0 (13.8) group: F1,244 = 56.51, P < .001
phase: F2,244 = 4.44, P < .05
group × phase: F2,244 = 3.92, P < .05

Note: GRFS, the Global Functioning Role Scale; GFSS, the Global Functioning Social Scale; BPRS, the Brief Psychiatric Rating Scale -24 item; RAD, Relationship Across Domains; MSCEIT, Mayer-Salovey-Caruso Emotional Intelligence Test 2.0; MCCB, MATRICS Consensus Cognitive Battery; SOP, Speed of Processing; AV, Attention/Vigilance; WM, Working Memory; Vrbl Lrng, Verbal Learning/Memory; Vis Lrng, Visual Learning/Memory; RPS, reasoning/problem solving. Values are given as mean (SD).